Raphé tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: Possible implications for tauopathies and Alzheimer's disease

Clément Menuet(Centre National de la Recherche Scientifique), Gérard Hilaire(Centre National de la Recherche Scientifique), Anne-Marie Lajard(Centre National de la Recherche Scientifique), Mathias Dutschmann(The University of Melbourne), Lies Gielis(KU Leuven), Peter Borghgraef(Allen Institute for Brain Science), Christian Gestreau(Centre National de la Recherche Scientifique), Fred Van Leuven(KU Leuven), Valéry Matarazzo(Inserm), Nicolas Voituron(Centre National de la Recherche Scientifique)
Respiratory Physiology & Neurobiology
July 8, 2011
10.1016/j.resp.2011.06.030
Cited by 33

Related Papers

Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain
|Journal of Biological Chemistry|1999|668
A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model
|Journal of Clinical Investigation|2004|622
Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1–42 levels in APPV717I transgenic mice
|Brain|2005|562
Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency
|Proceedings of the National Academy of Sciences|1999|523
Structural and Functional Characterization of Nrf2 Degradation by the Glycogen Synthase Kinase 3/β-TrCP Axis
|Molecular and Cellular Biology|2012|473